Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biopsy-site-marker in Breast Cancer
Sponsor: University of Oklahoma
Summary
The purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers. This study aims to determine whether the stiffness of a biopsy site marker promotes inflammatory changes in breast cancer and to evaluate whether there is a relationship between biopsy site marker stiffness and inflammation.
Official title: Inflammation and Biopsy-site-marker in Breast Cancer (MOSAIC)
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
140
Start Date
2026-07-09
Completion Date
2030-07
Last Updated
2026-09-22
Healthy Volunteers
No
Conditions
Interventions
Biopsy-Site Marker Placement.
Tissue samples will be collected from Breast Cancer patients, stages I-III, who underwent lumpectomy (mastectomy) after biopsy site marker placement during image-guided biopsy.
Locations (1)
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States